5K(top 5%)
articles
186.8K(top 4%)
citations
997(top 5%)
★★ articles
40(top 5%)
★★★ articles
3.5(top 9%)
Avg IF
169(top 3%)
H-Index
268(top 4%)
G-Index
838
journals

Most Cited Articles of Rega Institute for Medical Research in 2004

TitleJournalYearCitations
Antiviral drugs in current clinical useJournal of Clinical Virology2004758
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications2004441
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionJournal of Acquired Immune Deficiency Syndromes (1999)2004312
Antivirals and antiviral strategiesNature Reviews Microbiology2004275
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and futureChemistry and Biodiversity2004198
Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure ProphylaxisAntiviral Therapy2004161
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoidJournal of Pathology2004140
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplificationJournal of Virology2004137
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infectionAntimicrobial Agents and Chemotherapy2004135
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicidesAntimicrobial Agents and Chemotherapy2004130
Hantaviruses: immunology, treatment, and preventionViral Immunology2004121
Synthesis and antiviral evaluation of benzimidazoles, quinoxalines and indoles from dehydroabietic acidBioorganic and Medicinal Chemistry2004114
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1Current Topics in Medicinal Chemistry2004113
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compoundInternational Journal of Infectious Diseases2004101
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zosterBiochemical Pharmacology200499
Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxisAntiviral Therapy200496
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoproteinJournal of Virology200495
Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migrationJournal of Leukocyte Biology200489
The molecular population genetics of HIV-1 group OGenetics200489
HIV-chemotherapy and -prophylaxis: new drugs, leads and approachesInternational Journal of Biochemistry and Cell Biology200487
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectinsJournal of Virology200482
2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitorsAntiviral Research200482
Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonistJournal of Virology200476
Updated European Recommendations for the Clinical Use of HIV Drug Resistance TestingAntiviral Therapy200473
Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR techniquePediatric Transplantation200471